Αποτελέσματα Αναζήτησης
3 ημέρες πριν · MPM BioImpact’s investment team consists of professionals who have dedicated their careers to research and drug development, company creation, corporate strategy, and commercialization. Our Entrepreneur Partners provide deep domain expertise as investor-operators and work with our diverse group of scientists and professionals to develop ...
MPM BioImpact combines the expertise of MPM CAPITAL and BioImpact to create and invest in innovative biotechnology companies. It offers venture capital, impact funds and public equities funds with a focus on transformative therapies for patients.
Dr. Ansbert Gadicke is the Managing Partner of MPM BioImpact. Ansbert founded MPM Capital in 1992 as a biotech venture capital firm and later its affiliate BioImpact Capital for private/public funds.
MPM BioImpact is a venture capital and private equity firm that invests in biotechnology companies across the US and Europe. See its company size, location, specialties, employees, updates, and portfolio companies on LinkedIn.
MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes.
Founded in 1997, MPM Capital is a venture capital investment firm based in Boston, Massachusetts. The firm prefers to invest in the biotechnology, healthcare, and life sciences sectors in the United States. This firm is a Registered Investment Adviser (RIA).
6 Οκτ 2021 · MPM and its BioImpact Capital team raised $650 million for OIF 2 through their unique partnership with UBS, the world’s leading global wealth manager. UBS clients invested from around the world...
